Cariprazine D8 | CAS 1308278-69-4 - Request Quote
Cariprazine D8
| SZ CAT No: | SZ-C058D01 |
| CAS No | 1308278-69-4 |
| Mol.F. | C21H24D8Cl2N4O |
| Mol.Wt. | 435.5 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cariprazine D8 is chemically 3-((1r,4r)-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl-2,2-d2)cyclohexyl)-1,1-bis(methyl-d3)urea. Cariprazine D8 is supplied with detailed characterization data compliant with regulatory guideline. Cariprazine D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cariprazine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1308278-69-4
Purchase 1308278-69-4
Order 1308278-69-4
Enquire 1308278-69-4
price of 1308278-69-4
1308278-69-4 Supplier
1308278-69-4 Manufacturer
1308278-69-4 Exporter
buy high quality Cariprazine D8
Purchase Cariprazine D8
Cariprazine D8 suppliers
Cariprazine D8 manufacturers
Cariprazine D8 price
Order Cariprazine D8
Enquire Cariprazine D8
Cariprazine D8 cost
Cariprazine D8 Supplier
Cariprazine D8 Distributor
Cariprazine D8 for Method Validation
Cariprazine Reference Standard
Cariprazine D8 for ANDA Filing
Cariprazine D8 for Forced Degradation Studies
Cariprazine D8 Identification Standards
Cariprazine D8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


